Examines PMCA1's role in insulin secretion and glucose tolerance in β cells, suggesting new therapeutic insights.
Introduction and Objective: While glucose-dependent Ca²+ influx is central to pancreatic β cell insulin secretion, the mechanisms that control Ca²+ extrusion and their impact on insulin secretion have yet to be elucidated. As plasma membrane Ca²+ ATPase 1 (PMCA1) is the most highly expressed Ca²+ extrusion protein in β cells, we sought to determine how it regulates Ca²+ handling, insulin secretion, and glucose homeostasis. Methods: PMCA1 function was assessed in β cell-specific PMCA1 knockout mice (βPMCA1KO) and human pseudoislets with β cell-specific PMCA1 knockdown (βPMCA1KD). qPCR and Immunofluorescence were utilized to determine expression and subcellular localization of PMCA1. Islet Ca²+ was assessed to quantify glucose-stimulated Ca2+ dynamics. Insulin secretion was measured under basal and secretagogue-stimulated conditions. Additionally, intraperitoneal glucose tolerance testing was performed. Results: Mouse and human pancreata showed strong β cell PMCA1 staining specifically at the plasma membrane, which was lost in βPMCA1KO sections. βPMCA1KO islets showed a 73.9±34% increased glucose-stimulated Ca²+ oscillation period (P<.05), 46±23% reduction in peak-to-trough decay slope (P<.01), and a 51±32% increase in Ca²+ amplitude spike (P<.05). Consistent with enhanced Ca²+ signaling, βPMCA1KO mice displayed improved glucose tolerance (34±32% decrease in AUC; P<.001). This was further examined in human βPMCA1KD pseudoislets with a 93±3.6% reduction in ATP2B1, the mRNA encoding PMCA1 (P<.0001). βPMCA1KD pseudoislets showed elevated basal, first-phase, and KCl-stimulated insulin secretion (205±62%; P<.05, 69±19%; P<.05, 72±21%; P<.05, respectively). Interestingly, βPMCA1KD reduced insulin content 80±4.5% (P<.0001). Conclusion: PMCA1 is a key regulator of β-cell Ca²+ extrusion that reduces basal and glucose-stimulated Ca²+ influx and insulin secretion. Loss of human β cell PMCA1 promoted basal and glucose-stimulated insulin secretion, which likely depleted insulin content. Lastly, glucose tolerance was greatly improved in βPMCA1KO mice.
No takes yet. Share an insight, caveat, or question.
Peachee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: